Literature DB >> 15648075

UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency.

Antônio Lúcio Teixeira1, Débora P Maia, Francisco Cardoso.   

Abstract

Despite the renewed interest in Sydenham's chorea (SC) in recent years, there were no valid and reliable scales to rate the several signs and symptoms of patients with SC and related disorders. The Universidade Federal de Minas Gerais (UFMG) Sydenham's Chorea Rating Scale (USCRS) was designed to provide a detailed quantitative description of the performance of activities of daily living, behavioral abnormalities, and motor function of subjects with SC. The scale comprises 27 items and each one is scored from 0 (no symptom or sign) to 4 (severe disability or finding). Data from 84 subjects, aged 4.9 to 33.6 years, support the interrater reliability and internal consistency of the scale. The USCRS is a promising instrument for rating the clinical features of SC as well as their functional impact in children and adults. Copyright 2005 Movement Disorder Society.

Entities:  

Mesh:

Year:  2005        PMID: 15648075     DOI: 10.1002/mds.20377

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Current behavioral assessments of movement disorders in children.

Authors:  Tetsuya Asakawa; Kenji Sugiyama; Takao Nozaki; Tetsuro Sameshima; Susumu Kobayashi; Liang Wang; Zhen Hong; Shu-Jiao Chen; Can-Dong Li; Ding Ding; Hiroki Namba
Journal:  CNS Neurosci Ther       Date:  2018-07-24       Impact factor: 5.243

2.  Serum levels of brain-derived neurotrophic factor in Sydenham's chorea.

Authors:  Antônio Lúcio Teixeira; Thales Lage Bretas; Arthur Kummer; Lívia Cunha Melo; Amanda Baraldi; Estefânia Harsányi; Francisco Cardoso; Elizabeth Ribeiro da Silva Camargos
Journal:  Neurol Sci       Date:  2010-01-29       Impact factor: 3.307

3.  Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder.

Authors:  Jacinta Saldaris; Judith Weisenberg; Elia Pestana-Knight; Eric D Marsh; Bernhard Suter; Rajsekar Rajaraman; Gena Heidary; Heather E Olson; Orrin Devinsky; Dana Price; Peter Jacoby; Helen Leonard; Tim A Benke; Scott Demarest; Jenny Downs
Journal:  J Child Neurol       Date:  2021-08-11       Impact factor: 1.987

4.  Successful treatment of Sydenham's chorea with intravenous immunoglobulin.

Authors:  Nienke Anne Boersma; Herman Schippers; Taco Kuijpers; Jojanneke Heidema
Journal:  BMJ Case Rep       Date:  2016-02-01

5.  Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea.

Authors:  Hilla Ben-Pazi; Julie A Stoner; Madeleine W Cunningham
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 6.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01

Review 7.  Rating Scales for Movement Disorders With Sleep Disturbances: A Narrative Review.

Authors:  Carmen Rodríguez-Blázquez; Maria João Forjaz; Monica M Kurtis; Roberta Balestrino; Pablo Martinez-Martin
Journal:  Front Neurol       Date:  2018-06-07       Impact factor: 4.003

8.  Functional Impact of Sydenham's Chorea: A Case Report.

Authors:  Hortensia Gimeno; Sinead Barry; Jean-Pierre Lin; Anne Gordon
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-03-26

9.  Oxcarbazepine May Be Useful in Sydenham Chorea.

Authors:  Sedat Işıkay; Kutluhan Yılmaz
Journal:  Turk Arch Pediatr       Date:  2021-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.